发明名称 Modified release matrix formulation of cefaclor and cephalexin
摘要 A pharmaceutical composition in the form of a tablet for controlled release of an active ingredient comprises cefaclor, cephalexin, or their pharmaceutically acceptable hydrates, salts, or esters as active ingredient, and a mixture of hydrophilic polymers of different viscosity grades selected from the group consisting of at least one hydroxypropyl methylcellulose and at least one hydroxypropylcellulose. The composition optionally also contains one or more of a water soluble or water dispersible diluent. The quantities of the hydrophilic polymers and water soluble or water dispersible diluent are such that the therapeutically effective active ingredient is released at a rate suitable for twice daily administration of the pharmaceutical composition to human subjects. The tablets may also be coated with a rapidly dissolving water soluble polymeric film coat. In a preferred embodiment, the composition comprises about 50% to about 90% by weight of cefaclor, cephalexin, or their pharmaceutically acceptable hydrates, salts, or esters, and about 5% to about 35% of a mixture of hydrophilic polymers of different grades, wherein the hydrophilic polymers comprise about 0.1 % to about 20% by weight of hydroxypropyl methylcellulose and about 0.1 % to about 20% by weight of hydroxypropyl cellulose.
申请公布号 EP0923934(B1) 申请公布日期 2003.08.06
申请号 EP19980302445 申请日期 1998.03.30
申请人 RANBAXY LABORATORIES, LTD. 发明人 ARORA, JAGDISH;JAIN, GIRISH;SEN, HIMADRI
分类号 A61K9/20;A61K9/22;A61K9/28;A61K9/30;A61K31/545;A61K47/38 主分类号 A61K9/20
代理机构 代理人
主权项
地址